Keywords
How to Cite
Abstract
Following the devastating pandemic of COVID a new and concerning global threat “re-emergence of the Monkeypox virus” has occurred during May 2022. Viruses-based diseases cannot be ignored so preventive measures have been taken by the scientific community across the globe. Significant breakthroughs have been seen regarding the diagnosis and treatment of monkey virus infections leading to improved efficacy. Monkey virus, also considered as simian virus can affect primates including monkeys and humans. The accuracy and speed of diagnosis methods have been ameliorated by several paramount approaches, serological tests, viral culture, CRISPR-based identification, and PCR. Additionally, antiviral therapy advancements and supportive care strategies have shown significant results in the treatment of monkeypox infection. The efficacy of these diagnosis and treatment methods was discussed and challenges related to these techniques were highlighted. This review aims to provide a thorough insight into current trends in the diagnosis and treatment of the monkeypox virus that can serve as paramount information for public health authorities, researchers, and clinicians pertinent to effective management and control of these emerging viral diseases.
References
1. Anuradha M, Rao KR. Overview on Monkey Pox an Emerging Viral Infection. A Review of Literature. European Journal of Molecular & Clinical Medicine (EJMCM). 2023;10(01).
2. Faye O, Pratt CB, Faye M, Fall G, Chitty JA, Diagne MM, Wiley MR, Yinka-Ogunleye AF, Aruna S, Etebu EN, Aworabhi N. Genomic characterisation of human monkeypox virus in Nigeria. The Lancet. Infectious diseases. 2018;18(3):246.
3. Nakhaie M, Arefinia N, Charostad J, Bashash D, Haji Abdolvahab M, Zarei M. Monkeypox virus diagnosis and laboratory testing. Reviews in medical virology. 2023;33(1):e2404.
4. Shchelkunov SN. An increasing danger of zoonotic orthopoxvirus infections. PLoS pathogens. 2013;9(12):e1003756.
5. Yang Z, Gray M, Winter L. Why do poxviruses still matter?. Cell & bioscience. 2021;11(1):96.
6. Shchelkunov SN. Orthopoxvirus genes that mediate disease virulence and host tropism. Advances in Virology. 2012;2012(1):524743.
7. Challberg MD, Englund PT. Purification and properties of the deoxyribonucleic acid polymerase induced by vaccinia virus. Journal of Biological Chemistry. 1979;254(16):7812-9.
8. Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020;12(11):1257.
9. Kumar S, Subramaniam G, Karuppanan K. Human monkeypox outbreak in 2022. Journal of medical virology. 2023;95(1).
10. Grant RJ, Baldwin CD, Nalca A, Zoll S, Blyn LB, Eshoo MW, Matthews H, Sampath R, Whitehouse CA. Application of the Ibis-T5000 pan-orthopoxvirus assay to quantitatively detect monkeypox viral loads in clinical specimens from macaques experimentally infected with aerosolized monkeypox virus. The American journal of tropical medicine and hygiene. 2010;82(2):318.
11. Turner PC, Moyer RW. An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse. Journal of virology. 1992;66(4):2076-85.
12. Li Y, Olson VA, Laue T, Laker MT, Damon IK. Detection of monkeypox virus with real-time PCR assays. Journal of Clinical Virology. 2006;36(3):194-203.
13. Pal M, Mengstie F, Kandi V. Epidemiology, diagnosis, and control of monkeypox disease: a comprehensive review. Am J Infect Dis Microbiol. 2017;5(2):94-9.
14. Doty JB, Malekani JM, Kalemba LS, Stanley WT, Monroe BP, Nakazawa YU, Mauldin MR, Bakambana TL, Liyandja Dja Liyandja T, Braden ZH, Wallace RM. Assessing monkeypox virus prevalence in small mammals at the human–animal interface in the Democratic Republic of the Congo. Viruses. 2017;9(10):283.
15. Khodakevich L, Ježek Z, Messinger D. Monkeypox virus: ecology and public health significance. Bulletin of the World Health Organization. 1988;66(6):747.
16. Orba Y, Sasaki M, Yamaguchi H, Ishii A, Thomas Y, Ogawa H, Hang’ombe BM, Mweene AS, Morikawa S, Saijo M, Sawa H. Orthopoxvirus infection among wildlife in Zambia. Journal of General Virology. 2015;96(2):390-4.
17. Reynolds MG, Carroll DS, Olson VA, Hughes C, Galley J, Likos A, Montgomery JM, Suu-Ire R, Kwasi MO, Root JJ, Braden Z. A silent enzootic of an orthopoxvirus in Ghana, West Africa: evidence for multi-species involvement in the absence of widespread human disease. The American journal of tropical medicine and hygiene. 2010;82(4):746.
18. Salzer JS, Carroll DS, Rwego IB, Li Y, Falendysz EA, Shisler JL, Karem KL, Damon IK, Gillespie TR. Serologic evidence for circulating orthopoxviruses in peridomestic rodents from rural Uganda. Journal of wildlife diseases. 2013;49(1):125-31.
19. Li Y, Zhao H, Wilkins K, Hughes C, Damon IK. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA. Journal of virological methods. 2010;169(1):223-7.
20. Assessment RR. Monkeypox multi-country outbreak. Eur. Cent. Dis. Prev. Control. 2022.
21. Wallau GL, Maciel-de-Freitas R, Schmidt-Chanasit J. An unfolding monkeypox outbreak in Europe and beyond. Military Medical Research. 2022;9(1):31.
22. Rao AK. Monkeypox in a traveler returning from Nigeria—Dallas, Texas, July 2021. MMWR. Morbidity and Mortality Weekly Report. 2022;71.
23. Moss B. Poxvirus DNA replication. Cold Spring Harbor perspectives in biology. 2013;5(9):a010199.
24. Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: a comprehensive review of transmission, pathogenesis, and manifestation. Cureus. 2022;14(7)..
25. Moss B. Poxvirus cell entry: how many proteins does it take?. Viruses. 2012;4(5):688-707.
26. World Health Organization. Laboratory testing for the monkeypox virus: interim guidance. 2022.
27. Mucker EM, Wollen-Roberts SE, Kimmel A, Shamblin J, Sampey D, Hooper JW. Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease. PLoS Neglected Tropical Diseases. 2018;12(6):e0006581.
28. Weinstein RA, Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clinical infectious diseases. 2005;41(12):1765-71.
29. Padlipsky P, Young KD. Varicella and Zoster. Life-Threatening Rashes: An Illustrated, Practical Guide. 2018:141-58.
30. Dyall J, Johnson RF, Chen DY, Huzella L, Ragland DR, Mollura DJ, Byrum R, Reba RC, Jennings G, Jahrling PB, Blaney JE. Evaluation of monkeypox disease progression by molecular imaging. The Journal of infectious diseases. 2011;204(12):1902-11.
31. Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS neglected tropical diseases. 2022;16(2):e0010141.
32. Eshoo MW, Whitehouse CA, Nalca A, Zoll S, Ecker JA, Hall TA, Pennella TT, Duncan DD, Desai A, Moradi EK, Rudnick K. Rapid and high-throughput pan-Orthopoxvirus detection and identification using PCR and mass spectrometry. PLoS One. 2009;4(7):e6342.
33. Fenner F. Adventures with poxviruses of vertebrates. FEMS microbiology reviews. 2000;24(2):123-33.
34. Parker S, Buller RM. A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012. Future virology. 2013;8(2):129-57.
35. Cho CT, Wenner HA. Monkeypox virus. Bacteriological reviews. 1973;37(1):1-8.
36. Sood A, Sui Y, McDonough E, Santamaría-Pang A, Al-Kofahi Y, Pang Z, Jahrling PB, Kuhn JH, Ginty F. Comparison of multiplexed immunofluorescence imaging to chromogenic immunohistochemistry of skin biomarkers in response to monkeypox virus infection. Viruses. 2020;12(8):787.
37. Davi SD, Kissenkötter J, Faye M, Böhlken-Fascher S, Stahl-Hennig C, Faye O, Faye O, Sall AA, Weidmann M, Ademowo OG, Hufert FT. Recombinase polymerase amplification assay for rapid detection of Monkeypox virus. Diagnostic microbiology and infectious disease. 2019;95(1):41-5.
38. Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, Davidson W, Galloway R, Khristova ML, Reynolds MG, Zhao H. A tale of two clades: monkeypox viruses. Journal of General Virology. 2005;86(10):2661-72.
39. Iizuka I, Saijo M, Shiota T, Ami Y, Suzaki Y, Nagata N, Hasegawa H, Sakai K, Fukushi S, Mizutani T, Ogata M. Loop‐mediated isothermal amplification‐based diagnostic assay for monkeypox virus infections. Journal of medical virology. 2009;81(6):1102-8.
40. Li D, Wilkins K, McCollum AM, Osadebe L, Kabamba J, Nguete B, Likafi T, Balilo MP, Lushima RS, Malekani J, Damon IK. Evaluation of the GeneXpert for human monkeypox diagnosis. The American journal of tropical medicine and hygiene. 2017;96(2):405.
41. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature. 1999;402(Suppl 6761):C47-52.
42. Timp W, Timp G. Beyond mass spectrometry, the next step in proteomics. Science Advances. 2020;6(2):eaax8978.
43. Cristea IM, Graham D. Virology meets proteomics. Proteomics. 2015;15(12):1941.
44. Sperk M, Van Domselaar R, Rodriguez JE, Mikaeloff F, Sá Vinhas B, Saccon E, Sonnerborg A, Singh K, Gupta S, Vegvari A, Neogi U. Utility of proteomics in emerging and re-emerging infectious diseases caused by RNA viruses. Journal of Proteome Research. 2020;19(11):4259-74.
45. McCraith S, Holtzman T, Moss B, Fields S. Genome-wide analysis of vaccinia virus protein–protein interactions. Proceedings of the National Academy of Sciences. 2000;97(9):4879-84.
46. Gao M, Brufatto N, Chen T, Murley LL, Thalakada R, Domagala M, Beattie B, Mamelak D, Athanasopoulos V, Johnson D, McFadden G. Expression profiling of herpesvirus and vaccinia virus proteins using a high-throughput baculovirus screening system. Journal of Proteome Research. 2005;4(6):2225-35.
47. Chung CS, Chen CH, Ho MY, Huang CY, Liao CL, Chang W. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. Journal of virology. 2006;80(5):2127-40.
48. Yoder JD, Chen TS, Gagnier CR, Vemulapalli S, Maier CS, Hruby DE. Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins. Virology journal. 2006;3:1-6.
49. Lum KK, Cristea IM. Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection. Expert review of proteomics. 2016;13(3):325-40.
50. Maxwell KL, Frappier L. Viral proteomics. Microbiology and Molecular Biology Reviews. 2007;71(2):398-411.
51. Keasey S, Pugh C, Tikhonov A, Chen G, Schweitzer B, Nalca A, Ulrich RG. Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination. PLoS One. 2010;5(12):e15547.
52. Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of bacteriology. 1987;169(12):5429-33.
53. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. science. 2012;337(6096):816-21.
54. Teng M, Yao Y, Nair V, Luo J. Latest advances of virology research using CRISPR/Cas9-based gene-editing technology and its application to vaccine development. Viruses. 2021;13(5):779.
55. Jolany Vangah S, Katalani C, Boone HA, Hajizade A, Sijercic A, Ahmadian G. CRISPR-based diagnosis of infectious and noninfectious diseases. Biological procedures online. 2020;22:1-4.
56. . Yin L, Man S, Ye S, Liu G, Ma L. CRISPR-Cas based virus detection: Recent advances and perspectives. Biosensors and Bioelectronics. 2021;193:113541.
57. Foss DV, Hochstrasser ML, Wilson RC. Clinical applications of CRISPR‐based genome editing and diagnostics. Transfusion. 2019;59(4):1389-99.
58. Gootenberg JS, Abudayyeh OO, Lee JW, Essletzbichler P, Dy AJ, Joung J, Verdine V, Donghia N, Daringer NM, Freije CA, Myhrvold C. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 2017;356(6336):438-42.
59. Fozouni P, Son S, de León Derby MD, Knott GJ, Gray CN, D’Ambrosio MV, Zhao C, Switz NA, Kumar GR, Stephens SI, Boehm D. Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy. Cell. 2021;184(2):323-33.
60. Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, Miao X, Streithorst JA, Granados A, Sotomayor-Gonzalez A, Zorn K. CRISPR–Cas12-based detection of SARS-CoV-2. Nature biotechnology. 2020;38(7):870-4.
61. Sejvar JJ, Chowdary Y, Schomogyi M, Stevens J, Patel J, Karem K, Fischer M, Kuehnert MJ, Zaki SR, Paddock CD, Guarner J. Human monkeypox infection: a family cluster in the midwestern United States. The Journal of infectious diseases. 2004;190(10):1833-40.
62. Cheema AY, Ogedegbe OJ, Munir M, Alugba G, Ojo TK. Monkeypox: a review of clinical features, diagnosis, and treatment. Cureus. 2022;14(7).
63. Pastula DM, Tyler KL. An overview of monkeypox virus and its neuroinvasive potential. Annals of neurology. 2022;92(4):527-31.
64. Minhaj FS, Ogale YP, Whitehill F, Schultz J, Foote M, Davidson W, Hughes CM, Wilkins K, Bachmann L, Chatelain R, Donnelly MA. Monkeypox outbreak—Nine states, May 2022: 2022;71(23); 764–769.
65. World Health Organization. Surveillance, case investigation and contact tracing for monkeypox: interim guidance, 25 August 2022 (No. WHO/MPX/Surveillance/2022.3). World Health Organization .2022.
66. Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. The Lancet infectious diseases. 2004;4(1):15-25..
67. Hammarlund E, Lewis MW, Carter SV, Amanna I, Hansen SG, Strelow LI, Wong SW, Yoshihara P, Hanifin JM, Slifka MK. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nature medicine. 2005;11(9):1005-11.
68. Karem KL, Reynolds M, Braden Z, Lou G, Bernard N, Patton J, Damon IK. Characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clinical and Vaccine Immunology. 2005;12(7):867-72.
69. Bayer‐Garner IB. Monkeypox virus: histologic, immunohistochemical and electron‐microscopic findings. Journal of cutaneous pathology. 2005;32(1):28-34.
70. Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and treatment of monkeypox. Drugs. 2022;82(9):957-63.
71. CDC. Monkeypox. July 29, 2022. https://www.cdc.gov/poxvirus/monkeypox/index.html. Accessed July 30, 2022.
72. Centers for Disease Control and Prevention. Available online: http://www.cdc.gov/poxvirus/monkeypox/index.html (accessed on 13 May 2016).
73. Nolen LD, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, Doty J, Hughes CM, Kabamba J, Malekani J, Bomponda PL. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo. Emerging infectious diseases. 2016;22(6):1014.
74. Abbasi J. Reports of asymptomatic monkeypox suggest that, at the very least, some infections go unnoticed. Jama. 2022;328(11):1023-5.
75. World Health Organization. Clinical management and infection prevention and control for monkeypox interim rapid response guidance, 10 June 2022. 2022. https://www.who.int/publications/i/item/WHO-MPX-Clinical-and-IPC-2022.1. Accessed 20 Jun 2022.
76. Goyal L, Ajmera K, Pandit R, Pandit T. Prevention and treatment of monkeypox: a step-by-step guide for healthcare professionals and general population. Cureus. 2022;14(8).
77. Desai AN, Thompson GR, Neumeister SM, Arutyunova AM, Trigg K, Cohen SH. Compassionate use of tecovirimat for the treatment of monkeypox infection. Jama. 2022;328(13):1348-50.
78. Centers for Disease Control and Prevention. Guidance for Tecovirimat Use Under Expanded Access Investigational New Drug Protocol during 2022 U.S. 2022.
79. Centers for Disease Control and Prevention. Infection Prevention and Control of Monkeypox in Healthcare Settings. 2022.
80. Hughes AL, Irausquin S, Friedman R. The evolutionary biology of poxviruses. Infection, Genetics and Evolution. 2010;10(1):50-9.
81. See KC. Vaccination for monkeypox virus infection in humans: a review of key considerations. Vaccines. 2022;10(8):1342.
82. Centers for Disease Control and Prevention. Interim Clinical Guidance for the Treatment of Monkeypox. 2022.
83. UK Health Security Agency. Recommendations for the use of preand post-exposure vaccination during a monkeypox incident. 2022.
84. Bragazzi NL, Kong JD, Mahroum N, Tsigalou C, Khamisy‐Farah R, Converti M, Wu J. Epidemiological trends and clinical features of the ongoing monkeypox epidemic: a preliminary pooled data analysis and literature review. Journal of medical virology. 2023;95(1):e27931.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Pak-Euro Journal of Medical and Life Sciences